Shepherd FA, Dancey J, Ramlau R, Mattson K, Gralla R, O'Rourke M, Levitan N, Gressot L, Vincent M, Burkes R, Coughlin S, Kim Y, Berille J: Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol. 2000, 18: 2095-2103.
PubMed
CAS
Google Scholar
Cortes JE, Pazdur R: Docetaxel. J Clin Oncol. 1995, 13: 2643-2655.
PubMed
CAS
Google Scholar
Esmaeli B, Hortobagyi GN, Esteva FJ, Booser D, Ahmadi MA, Rivera E, Arbuckle R, Delpassand E, Guerra L, Valero V: Canalicular stenosis secondary to weekly versus every-3-weeks docetaxel in patients with metastatic breast cancer. Ophthalmology. 2002, 109: 1188-1191. 10.1016/S0161-6420(02)00989-2.
Article
PubMed
Google Scholar
Esmaeli B, Hidaji L, Adinin RB, Faustina M, Coats C, Arbuckle R, Rivera E, Valero V, Tu SM, Ahmadi MA: Blockage of the lacrimal drainage apparatus as a side effect of docetaxel therapy. Cancer. 2003, 98: 504-507. 10.1002/cncr.11527.
Article
PubMed
CAS
Google Scholar
Chan A, Su C, de Boer RH, Gajdatsy A: Prevalence of excessive tearing in women with early breast cancer receiving adjuvant docetaxel-based chemotherapy. J Clin Oncol. 2013, 31: 2123-2127. 10.1200/JCO.2012.45.6574.
Article
PubMed
CAS
Google Scholar
Segawa Y, Kiura K, Takigawa N, Kamei H, Harita S, Hiraki S, Watanabe Y, Sugimoto K, Shibayama T, Yonei T, Ueoka H, Takemoto M, Kanazawa S, Takata I, Nogami N, Hotta K, Hiraki A, Tabata M, Matsuo K, Tanimoto M: Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007. J Clin Oncol. 2010, 28: 3299-3306. 10.1200/JCO.2009.24.7577.
Article
PubMed
CAS
Google Scholar
Agustoni F, Platania M, Vitali M, Zilembo N, Haspinger E, Sinno V, Gallucci R, de Braud F, Garassino MC: Emerging toxicities in the treatment of non-small cell lung cancer: Ocular disorders. Cancer Treat Rev. 2014, 40: 197-203. 10.1016/j.ctrv.2013.05.005.
Article
PubMed
CAS
Google Scholar
Esmaeli B, Amin S, Valero V, Adinin R, Arbuckle R, Banay R, Do KA, Rivera E: Prospective study of incidence and severity of epiphora and canalicular stenosis in patients with metastatic breast cancer receiving docetaxel. J Clin Oncol. 2006, 24: 3619-3622. 10.1200/JCO.2005.04.4453.
Article
PubMed
CAS
Google Scholar
Kintzel PE, Michaud LB, Lange MK: Docetaxel-associated epiphora. Pharmacotherapy. 2006, 26: 853-867. 10.1592/phco.26.6.853.
Article
PubMed
CAS
Google Scholar
Esmaeli B, Ahmadi MA, Rivera E, Valero V, Hutto T, Jackson DM, Newman RA: Docetaxel secretion in tears: association with lacrimal drainage obstruction. Arch Ophthalmol. 2002, 120: 1180-1182. 10.1001/archopht.120.9.1180.
Article
PubMed
CAS
Google Scholar
Leyssens B, Wildiers H, Lobelle JP, Gillis A, Paridaens R, Mombaerts I: A double-blind randomized phase II study on the efficacy of topical eye treatment in the prevention of docetaxel-induced dacryostenosis. Ann Oncol. 2010, 21: 419-423. 10.1093/annonc/mdp319.
Article
PubMed
CAS
Google Scholar
McCartney E, Valluri S, Rushing D, Burgett R: Upper and lower system nasolacrimal duct stenosis secondary to paclitaxel. Ophthal Plast Reconstr Surg. 2007, 23: 170-171. 10.1097/IOP.0b013e318032e908.
Article
PubMed
Google Scholar
Sparano JA, Wang M, Martino S, Jones V, Perez EA, Saphner T, Wolff AC, Sledge GW, Wood WC, Davidson NE: Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med. 2008, 358: 1663-1671. 10.1056/NEJMoa0707056.
Article
PubMed
CAS
PubMed Central
Google Scholar